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1. INTRODUCTION 
Hormonally stimulated adenylate cyclase con- 
sists of at least 3 individual components: a receptor 
(R) which recognizes hormones or neurotransmit- 
ters; a GTP-binding component (G-protein, ab- 
breviated G, G/F or N); and a catalytic moiety (C) 
which generates the second messenger cAMP 
[1-4]. While considerable progress has been 
achieved in the purification of the G-protein [5-7] 
and the fl-adrenergic receptor [8,9] purification of 
the catalyst is lagging behind. This may in part be 
explained by its extreme instability and by the lack 
of suitable ligands for construction of affinity sup- 
ports which otherwise proved to be extremely use- 
ful for isolation of minute quantities of total cellu- 
lar protein [9,10]. The most notable success in 
purification of adenylate cyclase has been 
achieved with the canine myocardial enzyme by 
successive hydrophobic and affinity chromato- 
graphy on ATP-agarose [11]. However, the pro- 
cedure in [11] failed to resolve C and G since the 
purified material was still activated by Gpp(NH)p. 
The first successful separation of the catalyst and 
the regulatory G-protein has been achieved by 
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affinity chromatography of solubilized pigeon- 
erythrocyte membrane adenylate cyclase on GTP-  
Sepharose: While the G-protein was selectively re- 
tained by the resin, the catalytic part was ex- 
clusively found in the column pass-through [2]. 
Resolution of G and C by means of gel-filtration 
in the presence of cholate and high concentrations 
of ammonium sulfate has been reported indepen- 
dently by two groups [12,13]. Although the two 
functions were clearly separated by this method, 
purification of either function was poor. 
The hypotensive diterpene forskolin from the 
roots of Coleus forskohlii is a unique and potent 
stimulator of adenylate cyclase from a variety of 
sources [14-16]. This plant drug may be specifi- 
cally directed to the catalytic moiety of the enzyme 
[16]. This proposal was mainly based on the ability 
of the diterpene to stimulate adenylate cyclase 
from the cyc- variant of S 49 lymphoma cells [16] 
known to be functionally deficient in a regulatory 
G-protein. Furthermore, a water-soluble adenylate 
cyclase from rat testis, likewise insensitive to 
guanylnucleotides and fluoride ions, could be 
stimulated by the diterpene [16]. However, with 
both the cyc- enzyme and the testis enzyme, the 
extent of stimulation and the apparent affinity for 
the drug were greatly diminished. On the other 
hand, low concentrations of forskolin (1 /~M) am- 
plified the response of brain adenylate cyclase to 
several hormones and neurotransmitters. This 
could be interpreted to mean that the diterpene 
acts additionally at the receptor or (and) at the G- 
protein [161. 
This study explores the diterpene's potential 
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capability to serve as specific ligand for a purifica- 
tion of the catalytic part of the adenylate cyclase 
complex by affinity chromatography. Further- 
more, a matrix-bound forskolin derivative could 
be a valuable tool to decide whether the site of ac- 
tion of this compound is exclusively at the catalyst 
or in addition at another component of the com- 
plex. Even the possibility has to be considered that 
forskolin binds to a yet unidentified component of 
the adenylate cyclase system. 
2. MATERIALS AND METHODS 
ATP, Gpp(NH)p, creatine phosphate and 
creatine kinase were purchased from Boehringer 
(Mannheim). Succinic anhydride, carbonyldiimid- 
azole, D,L-isoproterenol and Tween 60 were ob- 
tained from Serva (Heidelberg). Tween 60 was de- 
ionized by passage through a mixed-bed ion 
exchanger (AG 501 x 8, from Bio Rad, Munich). 
Lubrol PX was obtained from Sigma (Munich). 
Sepharose 4B CL and Sephadex G-25 are products 
of Pharmacia (Uppsala). [a-32p]ATP (10-30 Ci/ 
mmol), c[3H]AMP (15-30 Ci/mmol), NaB3H4 
(4.7 Ci/mmol) and [3,5-3H]l-fluoro-2,4-dinitro - 
benzene (10-30 Ci/mmol) were from the Radio- 
chemical Centre (Amersham). All other chemicals 
were of the highest purity available. Doubly dis- 
tilled water was used throughout. Protein was de- 
termined as in [17] or, with [3H]fluorodinitroben- 
zene as in [18]. 
Soluble adenylate cyclase from cardiac muscle 
of New Zealand rabbits was prepared as in [19] 
using 5 mM Lubrol PX in 10 mM MOPS, 1 mM 
Mg2+/EDTA (pH 7.4) and membrane protein at 
10 mg/ml. The Lubrol extract was centrifuged at 
200 000 x g for 60 min. A floating turbid layer 
was discarded and the clear supernatant saved. 
Persistently active adenylate cyclase refers to a 
solubilized preparation derived from myocardial 
membranes previously incubated with 100 ttM 
D,L-isoproterenol and 100 /xM Gpp(NH)p for 10 
min at 37°C before solubilisation with Lubrol PX 
as above. G-protein in the Gpp(NH)p charged 
form was purified from duck erythrocyte mem- 
branes [20] applying a modification of the pro- 
cedure in [6]. Rat brain adenylate cyclase was sol- 
ubilized as in [21] with minor modifications. 
2.1. Adenylate cyclase 
Adenylate cyclase assays in the presence of 0.1 
mM ATP, unless otherwise stated were performed 
at 32°C for 10 min as in [2]. cAMP production was 
linear with time for at least 20 min. Activators at 
the following final concentrations were added: 
MnCI2, 2 mM; Gpp(NH)p, 100 ttM; NaF, 10 mM; 
forskolin, 100 ~tM. Forskolin (or derivatives) were 
added to the assay mixtures as concentrated 
ethanolic solutions. Control samples also received 
ethanol at 0.5% final conc. 
Comparable results to these were obtained in at 
least 3 independent experiments. Standard devia- 
tions of triplicate determinations were < 4% of the 
means. 
2.2. Forskolin-Sepharose 
Forskolin (7fl-acetoxy-8, 13-epoxy-In, 6fi, 9a-tri- 
hydroxylabd-14-en-ll-one, C22H3407) was con- 
verted to deacetylforskolin by alkaline saponifica- 
tion [22]. 7-O-hemisuccinyl-7-deacetylforskolin was
synthesized by acylation of deacetylforskolin with 
succinic anhydride in pyridine. Purification and 
characterisation f the acylation products will be 
published elsewhere [23]. Aminoethyl-Sepharose 
4B CL was prepared by the cyanogen bromide 
method [24] or by the carbonyldiimidazole method 
[25]. Aminoethyl-Sepharose was coupled to 7- 
hemisuccinyldeacetylforskolin via the N-hydroxy- 
succinimide ster according to [26]. To facilitate 
quantitation of matrix-bound iterpene, a trace 
amount of NaB3H4-reduced forskolin derivative 
was added before coupling. 
Following hydrolysis with methanolic KOH, 
1 ml of packed resin was estimated to contain 0.4- 
0.8 Fmol forskolin derivative. For the sake of sim- 
plicity the immobilized diterpene will be desig- 
nated 'forskolin-Sepharose' in the following. 
HO O~ A fl'13 HO.~.~"" CH=CH2 
H3 
/~OF-I~-(CH2) -1CI-~N-(CH2I 2 -N- SEPHAROSE 
c;~3 c~ 8 0 
Fig.1. Forskolin-Sepharose 4B. 
370 
Volume 146, number 2 FEBS LETTERS September 1982 
3. RESULTS AND DISCUSSION 
Considering its chemical nature as an oligohy- 
droxy derivative [22] several hemisuccinate d riva- 
tives of forskolin have been synthesized. Direct 
succinylation of forskolin yielded a homogeneous 
derivative which, however, was barely activating 
myocardial adenylate cyclase exhibiting a Kact at 
least 2 orders of magnitude higher (> 5 x 10 -4 M) 
than the parent compound (3 x 10 -6 M). Optimal 
derivatisation of forskolin resulted from the re- 
placement of the 7-acetyl group by a succinyl 
group through acylation of deacetylforskolin with 
succinic anhydride: 7-hemisuccinyl-deacetyl-for- 
skolin exhibited a Kac t of 9 × 10- 6 M with a Vmax 
approaching 60% of that of forskolin. This deriva- 
tive is readily coupled to aminoethyl-Sepharose 
via its N-hydroxysuccinimide-ester. 
The experiment in fig.2 reveals that the immo- 
bilized forskolin-derivative is indeed able to retain 
adenylate cyclase activity from solubilized myocar- 
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Fig.2. Affinity chromatographic purification of 
solubilized rabbit myocardial adenylate cyclase on 
forskolin-Sepharose. Lubrol PX solubilized rabbit 
myocardial membranes (2ml, 1.5 mg/ml) were applied 
to a forskolin-Sepharose column (0.5 x 2 cm) equilibr- 
ated with 10 mM MOPS, 100 mM NaC1, 1 mM MgCI2, 
1 mM EDTA, 1 mM Tween 60 (pH 7.4, buffer A) at 4°C 
at 1.5 ml/h. The material was washed with another 2ml 
buffer A at the same rate. Non-retained protein was 
washed out with 6 column volumes of buffer A at 4 ml/ 
h. Specifically absorbed material was released from the 
column by inclusion of 100/~M forskolin into the elution 
buffer (arrow). Aliquots 20 ~tl of the fractions (0.2 ml) 
were assayed for adenylate cyclase activity in the 
presence of 100 ~M forskolin as in section 2. 
dial membranes. The vast majority of total protein 
applied to the column is found in the pass- 
through. Moreover, matrix-bound activity can be 
specifically and rapidly released by free forskolin. 
While > 90% of the activity applied to the column 
is bound, 35-55% can be recovered by elution 
with the diterpene following extensive washing 
with salt and detergent. This one-step procedure 
yields a 300-500-fold enrichment of forskolin- 
stimulated adenylate cyclase activity. Although de- 
tergent alone is not able to release forskolin- 
Sepharose-adsorbed adenylate cyclase activity, its 
presence together with the diterpene in the elution 
buffer is absolutely required*. 
Stimulation by forskolin of adenylate cyclase 
from several tissues is readily reversible following 
washing of treated cells or membranes [15]. We are 
confirming this with the soluble myocardial en- 
zyme which was depleted from forskolin by gel-fil- 
tration on Sephadex G-25. This enabled us to 
monitor the affinity-purified enzyme for its re- 
sponse to other activators whose actions would 
have been obscured in the presence of diterpene. 
The purified enzyme has become refractory to 
those activators which are known to act through 
the GTP-binding component (table 1). However, 
the ratios of Mn 2+ - or forskolin-stimulated to non- 
stimulated activities are essentially the same as 
with the control preparation. The material specifi- 
cally desorbed from the immobilized diterpene, 
however, has preserved its ability to interact with 
the separated G-protein fraction or with a purified 
G-protein from duck erythrocyte membranes. 
These data confirm the idea that the action of 
diterpene is indeed on the catalytic portion of the 
adenylate cyclase complex. 
Forskolin-Sepharose could be successfully ap- 
plied in recovery of adenylate cyclase from mem- 
branes of rat brain cortex [23]. Fig.3 shows dif- 
ferent functions of solubilized rat brain adenylate 
cyclase before and after forskolin-Sepharose 
chromatography. In accordance with the results 
obtained with the myocardial enzyme the affinity 
column efficiently resolves the catalytic part from 
the proteins required for stimulation by guanyl- 
*Desorption of adenylate cyclase activity was carried 
out in the presence of Tween 60 which is much less 
inhibitory than Lubrol PX, especially at low protein- 
detergent ratios 
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Table 1 
Refractoriness of tors•olin-Sepharose-purified myocardial denylate cyclase towards 
guanyl nucleotides and NaF 
Preparation Adenylate cyclase activity (nmol. mg l. min-l) 
in the presence of: 
None Mn 2 + Gpp(NH)p NaF Forskolin G-protein a 
Crude, solubilized 0.13 0.53 0.57 0.65 1.56 1.71 
Forskolin-Sepharose 
eluate 59.2 239.1 58.8 53.7 536 497 
a When reconstitution ofactivity by the G-protein was measured, 30 ng purified pro- 
tein (in the Gpp(NH)p-form) from duck erythrocyte membranes were added to the 
assay mixture 
Solubilized myocardial adenylate cyclase (400/~1, .45 mg/ml; crude preparation) or 
400 ~1 pooled fractions 60-80 from fig.1 (forskolin-Sepharose eluate) were chro- 
matographed on a Sephadex G-25 fine column (1 × 6.4 cm) equilibrated with 10 mM 
MOPS, 100 mM NaCI (pH 7.4). For proper control crude preparation was incubated 
with 100 /~M forskolin at 4°C for 60 min before gel-filtration; 10 ~tl aliquots were 
assayed for adenylate cyclase activity as in section 2 
nucleotides and fluoride. In addition, the brain en- 
zyme has also been desensitized towards Ca 2+. 
Like the enzyme from other tissues [27], myocar- 
dial adenylate cyclase can be persistently activated 
by pretreatment with GTP-analogues like Gpp- 
(NH)p or GTP,/S, especially in the presence of cat- 
echolamines. This persistent activation remains 
after subsequent solubilisation and further frac- 
tionation by gel-filtration or sucrose density cen- 
trifugation. With the latter technique, using 
[32p]ADP-ribosylated G-protein [28] and resolved 
catalytic function, we could show that the per- 
sistently activated system represents a G • C com- 
plex of the enzyme [3]. It is of interest hat this 
highly active species of adenylate cyclase can still 
be activated further by forskolin (1.6-2-fold). The 
concentration of forskolin required for half-maxi- 
mal stimulation appears to be one magnitude 
lower for the activated form of adenylate cyclase 
when compared with the non-activated enzyme 
(not shown). It was therefore to be expected that 
the persistently activated form binds also to the 
immobilized diterpene (table II). If forskolin- 
Sepharose-purified nzyme is freed from excess 
forskolin by gel-filtration, two properties dis- 
tinguish this form of the enzyme from a corre- 
sponding preparation but derived from mem- 
branes not pre-treated with Gpp(NH)p. It displays 
high basal activity in the absence of added Gpp- 
(NH)p or activated G-protein, both of which fail 
to increase the activity further. A plausible expla- 
nation for the persistence of the high activity state 
would be that this form, most likely the G • C com- 
plex, became resistant to affinity chromatographic 
purification on forskolin-Sepharose. Preliminary 
experiments showed that the affinity-purified en- 
zyme from persistently-activated membranes sedi- 
ments with a higher s20,w-value (8.7) in a sucrose 
density gradient han the corresponding prepara- 
tion from native membranes ( 20,w = 7.0). 
Affinity chromatography of preactivated soluble 
adenylate cyclase is more efficient than with the 
non-activated enzyme. In the former case, better 
recovery and higher purification presumably due 
to improved stability is achieved. A second proper- 
ty of the affinity-purified enzyme from Gpp- 
(NH)p-treated membranes, which differs from the 
behavior of the crude soluble preparation from 
which it is derived, is that the purified enzyme has 
become refractory to further stimulation by for- 
skolin. Tightly-bound diterpene in the enzyme 
preparation would explain this behavior. In fact, 
after chromatography on disulfide-Sepharose, 
stimulation by forskolin (and binding to for- 
skolin-Sepharose) reappears. But final proof 
requires following the partition of radioactively- 
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Table 2 
Forskolin-Sepharose chromatography of persistently activated adenylate 
cyclase 
Preparation Adenylate cyclase activity (nmol. mg -1 . min l) 
in the presence of: 
None G-protein a Forskolin 
Gpp(NH)p-preactivated 5.1 5.0 8.6 
Forskolin-Sepharose 
eluate 2688 2520 2666 
a30 ng purified G-protein (Gpp(NH)p form) from duck erythrocyte in
buffer A was added to the assay mixture 
Lubrol PX solubilized preparation (1 ml) of persistently (Gpp(NH)p-pre- 
treated) activated myocardial adenylate cyclase was mixed with 0.5 ml 
packed forskolin-Sepharose (in buffer A, containing 300 mM NaCI) and 
gently shaken for 120 min at 4°C. The mixture was centrifuged at 1000 x g 
for 2 min and the supernatant removed. After washing the beads with buffer 
A (3 times, 2 ml each), adenylate cyclase was released by addition of 100 ~tM 
forskolin to the slurry and adjusted to the original volume (1.5 ml). After 
gently agitating for 60 min at 4°C, the slurry was spun down as above and 
the supernatant removed (forskolin-Sepharose eluate). When assayed in 
the presence of 100 /~M forskolin adenylate cyclase activity of the non- 
retained material was 15%, while that of the forskolin-released material was 
55% of control activity. For control purposes, the starting material was like- 
wise treated with 100 ~M forskolin for 60 min at 4°C. Excessive diterpene 
was removed in each case by gel-filtration of 400 ~1 aliquots over Sephadex 
G-25 fine as in table 1. Adenylate cyclase activity was measured in the pres- 
ence or absence of 100 ~M forskolin as in section 2 except hat 1 mM 
[a-32p]ATP served as substrate 
labeled forskolin (or a derivative). 
This study demonstrates the usefulness of the 
immobilized adenylate cyclase activator forskolin 
for selective recovery of the enzyme from 
solubilized membrane preparations. This novel 
affinity support is easily synthesized. Moreover, 
binding and desorption of adenylate cyclase 
activity are specific resulting in considerable 
purification in one step. Finally, bound forskolin 
can be removed from the purified enzyme, thus 
making possible repeated cycles of chromatog- 
raphy using the same affinity support system. For- 
skolin-Sepharose can be regenerated by treat- 
ment, for instance with urea, with negligible losses 
of active ligand. 
These data indicate that activation of adenylate 
cyclase by the diterpene results from a direct inter- 
action with the catalyst (or a component closely as- 
sociated with it). A mechanism requesting the re- 
moval of an inhibitory component can be dis- 
carded. Further studies must show whether the 
forskolin binding site is located on the same poly- 
peptide chain which bears the catalytic site. 
However, the nearly complete lack of a response of 
adenylate cyclase from duck and pigeon erythro- 
cyte membranes to forskolin activation and the 
failure of immobilized forskolin to bind to these 
adenylate cyclases [23], shows that at least in these 
cases a separate forskolin binding component 
should be seriously considered. 
The forskolin-Sepharose d rivative is versatile, 
since it binds different forms of adenylate cyclase 
non-activated and persistently; e.g., Gpp(NH)p (or 
Mg2+/F -)  activated enzymes. When non-acti- 
vated adenylate ¢yclase is chromatographed, a 
preparation is obtained which is apparently re- 
solved from the regulatory G-protein (and from 
calmodulin in the case of the brain enzyme). G- 
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Fig.3. Loss of nucleotide-, fluoride- and Ca 2+ stimula- 
tion of rat brain adenylate cyclase following forskolin- 
Sepharose chromatography. Solubilized rat brain aden- 
ylate cyclase (1 ml, 1.2 mg protein) was mixed with 0.5 
ml packed forskolin-Sepharose in buffer A (containing 
300 mM NaC1 and 0.6 mM EGTA) and gently shaken 
for 120 min at 4°C. The slurry was then centrifuged at 
1000 x g for 2 min and the supernatant saved. Follow- 
ing 3-times washing of the resin with 2 ml each of buffer 
A, containing 0.2 mM EGTA, adenylate cyclase was re- 
leased with 100/~M forskolin added to the slurry in the 
original volume (1.5 ml). After gently agitating the mix- 
ture for 60 min, the released protein was separated by 
centrifugation as above (forskolin-Sepharose purified). 
A control preparation was likewise diluted with the 
above buffer and incubated in the presence of 100 #M 
forskolin for 60 min. Forskolin was removed from con- 
trol and affinity purified fraction by passage over 
Sephadex G-25 following the protocol in table 1. Aden- 
ylate cyclase activity in the presence and absence of the 
activators was determined as in section 2 with the excep- 
tion that 2 mM cAMP and 0.2 mM EGTA were present 
in the assay mixture. When stimulation by Ca 2+ was as- 
sayed, 0.25 mM CaC12 was added. In a typical experi- 
ment, 80% of the adenylate cyclase activity (measured in 
the presence of 100 ~M forskolin) was retained by the 
affinity column of which -50% could be recovered by 
elution with forskolin. Note the different scales in both 
panels. 
protein dependent activities are, however, fully re- 
stored on addition of G-protein containing extracts 
from the same tissue or on addition of a purified 
regulatory protein from duck erythrocyte mem- 
branes. 
This novel affinity support for adenylate cyclase 
should be valuable for both analytic and prepara- 
tive purposes and should be applicable to large- 
scale purification of this enzyme. 
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